Volume 23, Issue 5 pp. 399-401

Influence of calcium antagonist drugs in myasthenia gravis in the elderly

M. A. Pina Latorre

M. A. Pina Latorre

Service of Neurology, Hospital Obispo Polanco, Avda. Ruiz Jarabo s/n, E-44002 Teruel, Spain

Search for more papers by this author
J. C. Cobeta

J. C. Cobeta

Service of Rheumatology, Hospital Obispo Polanco, Avda. Ruiz Jarabo s/n, E-44002 Teruel, Spain

Search for more papers by this author
F. Rodilla

F. Rodilla

Service of Pharmacy, Hospital Obispo Polanco, Avda. Ruiz Jarabo s/n, E-44002 Teruel, Spain

Search for more papers by this author
N. Navarro

N. Navarro

Service of Ophthalmology, Hospital Obispo Polanco, Avda. Ruiz Jarabo s/n, E-44002 Teruel, Spain

Search for more papers by this author
S. Zabala

S. Zabala

Service of Internal Medicine, Hospital Obispo Polanco, Avda. Ruiz Jarabo s/n, E-44002 Teruel, Spain

Search for more papers by this author
First published: 09 October 2008
Citations: 13
Dr Miguel AngelPina Latorre Vía Pignatelli 21–23, 7°E, E-50007 Zaragoza, Spain.

Abstract

A number of drugs have been reported to cause neuromuscular blockade and/or to increase weakness in myasthenia gravis. We report on two patients, treated with felodipine and nifedipine for arterial hypertension, who presented with an exacerbation of their myasthenia gravis and a myasthenic syndrome or exacerbation of myasthenia gravis, respectively. The mechanism of action of calcium antagonist drugs at the neuromuscular junction is not yet well established, but it could be located at both presynaptic and postsynaptic levels.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.